silybin has been researched along with Neurodegenerative Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Huo, Q; Qi, Y; Shi, Y; Sui, H; Zhao, L | 1 |
| Haddadi, R; Komaki, A; Mahboobian, MM; Makhdoomi, S; Mohammadi, M | 1 |
| Chavarría, A; García, E; Meza, C; Pérez-Ramírez, DJ; Ramírez-Carreto, RJ; Rodríguez-López, BE; Santamaría, A; Zaldívar-Machorro, VJ | 1 |
| Chen, Y; Fujisaki, H; Hattori, S; Hayashi, T; Ikejima, T; Liu, P; Liu, W; Liu, X; Mizuno, K; Wang, C | 1 |
4 other study(ies) available for silybin and Neurodegenerative Diseases
| Article | Year |
|---|---|
Biomimetic silibinin-loaded macrophage-derived exosomes induce dual inhibition of Aβ aggregation and astrocyte activation to alleviate cognitive impairment in a model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Biomimetics; Cognitive Dysfunction; Disease Models, Animal; Exosomes; Macrophages; Mice; Neurodegenerative Diseases; Silybin | 2021 |
Silibinin-loaded nanostructured lipid carriers (NLCs) ameliorated cognitive deficits and oxidative damages in aluminum chloride-induced neurotoxicity in male mice.
Topics: Aluminum Chloride; Animals; Antioxidants; Cognition; Cognitive Dysfunction; Drug Carriers; Lipids; Male; Mice; Nanostructures; Neurodegenerative Diseases; Neurotoxicity Syndromes; Oxidative Stress; Particle Size; Silybin | 2022 |
Oral Administration of Silybin Protects Against MPTP-Induced Neurotoxicity by Reducing Pro-inflammatory Cytokines and Preserving BDNF Levels in Mice.
Topics: Administration, Oral; Animals; Brain-Derived Neurotrophic Factor; Cytokines; Disease Models, Animal; Dopamine; Mice; MPTP Poisoning; Neurodegenerative Diseases; Silybin | 2023 |
Silibinin attenuates motor dysfunction in a mouse model of Parkinson's disease by suppression of oxidative stress and neuroinflammation along with promotion of mitophagy.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopaminergic Neurons; Mice; Mice, Inbred C57BL; Mitophagy; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Silybin; Substantia Nigra | 2021 |